EOLS – evolus, inc. (US:NASDAQ)
Stock Stats
News
AEON Biopharma Abstract Accepted for Presentation at 2026 American Academy of Neurology (AAN) Annual Meeting [Yahoo! Finance]
Evolus, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Evolus (EOLS) had its "buy" rating reaffirmed by BTIG Research. They now have a $13.00 price target on the stock.
Evolus, Inc. (EOLS) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Evolus outlines 2026 revenue guidance of $327M–$337M while expanding international presence and product portfolio [Seeking Alpha]
Form S-8 Evolus, Inc.
Form 10-K Evolus, Inc. For: Dec 31
Form 8-K Evolus, Inc. For: Mar 03
Form 4 Evolus, Inc. For: Feb 17 Filed by: Parschauer Karah Herdman
Form 4 Evolus, Inc. For: Feb 17 Filed by: Mitchell Tatjana
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.